NEW YORK, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating R1 RCM Inc. (Nasdaq: RCM), relating to its proposed sale to investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice. Under the terms of the agreement, RC ...

Core Viewpoint - Wohl & Fruchter LLP is investigating the fairness of R1 RCM, Inc.'s sale price of $14.30 per share to TowerBrook Capital Partners and Clayton, Dubilier & Rice, which is below the target prices set by Wall Street analysts [1][3]. Group 1: Sale Details - RCM agreed to be sold for $14.30 per share in cash, as recommended by a Special Committee of RCM's board of directors [3]. - As of March 28, 2024, TowerBrook already owned 35.7% of RCM's common stock [3]. Group 2: Analyst Price Targets - The sale price of $14.30 is below the target prices set by various Wall Street analysts, including: - $20.00 by Charles Rhyee of TD Cowen - $19.00 by Sean Dodge of RBC Capital - $18.00 by Vikram Kesavabhotla of Robert W. Baird - $18.00 by Glen Santangelo of Jefferies - $17.00 by Jack Wallace of Guggenheim - $17.00 by Michael Cherny of Leerink Partners [3]. Group 3: Investigation Focus - The investigation will assess whether the RCM Board of Directors acted in the best interests of shareholders, the independence of the Special Committee, the fairness of the agreed price, and the completeness of information disclosed regarding the transaction [3].

MILWAUKEE, Aug. 1, 2024 /PRNewswire/ -- Ademi LLP is investigating R1 (NASDAQ: RCM) for possible breaches of fiduciary duty and other violations of law in its transaction with TowerBrook and CD&R. Click here to learn how to join our investigation https://www.ademilaw.com/case/r1rcm-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you. R1 stockholders will receive only $14.30 per share in an all-cash transaction with an enterprise value of approximately $8.9 billion. TowerB ...

MURRAY, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to be acquired by investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice ("CD&R"), in an all-cash transaction with an enterprise value of approximately $8.9 billion. An invest ...

You can find more information on all of these metrics, and much more, on Zacks.com. Heading into today, shares of the company had gained 8.3% over the past month, outpacing the Business Services sector's loss of 0.49% and the S&P 500's gain of 0.1% in that time. Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for RCM Technologies, Inc. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estim ...

Shares of this company have returned +5.7% over the past month versus the Zacks S&P 500 composite's -0.3% change. The Zacks Staffing Firms industry, to which RCM Technologies belongs, has gained 2.6% over this period. Now the key question is: Where could the stock be headed in the near term? Revisions to Earnings Estimates We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up ...

MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended June 30, 2024, before market open on Wednesday, August 7, 2024 and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by ...

The the stock of company has fallen by 3.94% in the past month, lagging the Business Services sector's gain of 0.23% and the S&P 500's gain of 4.44%. Investors will be eagerly watching for the performance of RCM Technologies, Inc. in its upcoming earnings disclosure. On that day, RCM Technologies, Inc. is projected to report earnings of $0.56 per share, which would represent year-over-year growth of 19.15%. Simultaneously, our latest consensus estimate expects the revenue to be $69.9 million, showing a 4.27 ...

The investment community will be closely monitoring the performance of RCM Technologies, Inc. in its forthcoming earnings report. The company's earnings per share (EPS) are projected to be $0.56, reflecting a 19.15% increase from the same quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $69.9 million, up 4.27% from the year-ago period. For the full year, the Zacks Consensus Estimates project earnings of $2.28 per share and a revenue of $278.04 million, demons ...

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, RCM Technologies is rated Zacks Rank #4 (Sell). Although media reports or rumors about a significant change in a company's business p ...